Early and Late CNS Inflammation in Alzheimer's Disease: Two Extremes of a Continuum?

scientific article published on 31 August 2017

Early and Late CNS Inflammation in Alzheimer's Disease: Two Extremes of a Continuum? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.TIPS.2017.07.005
P698PubMed publication ID28867259

P50author???Q92741319
P2093author name stringA Claudio Cuello
P2860cites workA Unique Microglia Type Associated with Restricting Development of Alzheimer's DiseaseQ38672340
P433issue11
P921main subjectAlzheimer's diseaseQ11081
P304page(s)956-966
P577publication date2017-08-31
P1433published inTrends in Pharmacological SciencesQ2451474
P1476titleEarly and Late CNS Inflammation in Alzheimer's Disease: Two Extremes of a Continuum?
P478volume38

Reverse relations

cites work (P2860)
Q91973479A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
Q99545663Alzheimer's disease: natural products as inhibitors of neuroinflammation
Q90304860Comparative benefits of simvastatin and exercise in a mouse model of vascular cognitive impairment and dementia
Q59791994Contribution of Neurons and Glial Cells to Complement-Mediated Synapse Removal during Development, Aging and in Alzheimer's Disease
Q92699153Decreased Netrin-1 and Correlated Th17/Tregs Balance Disorder in Aβ1-42 Induced Alzheimer's Disease Model Rats
Q58794404Differential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer's patients in a human blood brain barrier model
Q59328931Distinct Microglial Responses in Two Transgenic Murine Models of TAU Pathology
Q91687423Distribution and Relative Abundance of S100 Proteins in the Brain of the APP23 Alzheimer's Disease Model Mice
Q90117079Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain
Q92856694Entanglement of CCR5 and Alzheimer's Disease
Q64067761Experimental Pharmacology in Transgenic Rodent Models of Alzheimer's Disease
Q59136184Functional alterations of myeloid cells during the course of Alzheimer's disease
Q89806014Inhibitory Effects of Raw-Extract Centella asiatica (RECA) on Acetylcholinesterase, Inflammations, and Oxidative Stress Activities via In Vitro and In Vivo
Q89714624Innate sensing of mechanical properties of brain tissue by microglia
Q92800212Is Innate Memory a Double-Edge Sword in Alzheimer's Disease? A Reappraisal of New Concepts and Old Data
Q61799989Lipoxin A4 Regulates Lipopolysaccharide-Induced BV2 Microglial Activation and Differentiation via the Notch Signaling Pathway
Q55073016Microglia in Alzheimer's Disease: Activated, Dysfunctional or Degenerative.
Q47251476Multi-Protection of DL0410 in Ameliorating Cognitive Defects in D-Galactose Induced Aging Mice
Q94599572N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer's disease
Q93079510Neurodegeneration and Neuro-Regeneration-Alzheimer's Disease and Stem Cell Therapy
Q91762131Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer's disease
Q64948487S100 Proteins in Alzheimer's Disease.
Q91819996Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy
Q51765788Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.
Q96127618The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease
Q88738698The potential importance of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of Alzheimer's disease
Q64261246Trans ε viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model

Search more.